Bank of New York Mellon’s Rapid Micro Biosystems RPID Stock Holding History

Bank of New York Mellon’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,934	Closed	-$33.8K	–	4432
2022 Q4	$33.8K	Sell	29,934 -1	-0%	-$2	﹤0.01%	4289
2022 Q3	$96K	Sell	29,935 -65	-0.2%	-$252	﹤0.01%	4206
2022 Q2	$129K	Sell	30,000 -33,178	-53%	-$154K	﹤0.01%	4178
2022 Q1	$429K	Buy	63,178 +44,482	+238%	+$328K	﹤0.01%	3804
2021 Q4	$199K	Buy	18,696 +3,037	+19%	+$47.4K	﹤0.01%	4276
2021 Q3	$289K	Buy	+15,659	New	+$323K	﹤0.01%	4054

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

RMC

Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon's RPID Position: Q1 2023 in Review

Bank of New York Mellon sold out of Rapid Micro Biosystems (RPID) in Q1 2023, closing a stake of 29,934 shares — an estimated $33.8K sold.

Bank of New York Mellon first reported a position in RPID in Q3 2021 and held it in 6 quarters. The position peaked at $429K in Q1 2022. 31 funds tracked by Wall St. Rank hold RPID as of Q1 2023.

Bank of New York Mellon reported no remaining Rapid Micro Biosystems position as of Q1 2023 after selling out during the quarter.
Bank of New York Mellon sold 29,934 Rapid Micro Biosystems shares in Q1 2023, an estimated $33.8K.
Bank of New York Mellon first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 6 quarters.
Bank of New York Mellon's Rapid Micro Biosystems position peaked at $429K in Q1 2022.
31 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2023.

Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.